Aizant
Hyderabad, India· Est.
Integrated Indian CDMO/CRO delivering AI‑enhanced drug development and manufacturing services worldwide.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Integrated Indian CDMO/CRO delivering AI‑enhanced drug development and manufacturing services worldwide.
CardiovascularOncologyAntidiabeticAntiviralAntibiotics
Technology Platform
Integrated AI/ML‑driven process platform combining hot‑melt extrusion, spray‑drying, and advanced analytical labs to accelerate API and formulation development while ensuring regulatory compliance.
Opportunities
Expansion of AI‑enabled CDMO services and increased demand for end‑to‑end drug development solutions in emerging markets.
Risk Factors
Regulatory scrutiny, capacity constraints, and intense competition from global CDMO players.
Competitive Landscape
Competes with multinational CDMOs such as Lonza, Patheon, and Cambrex; differentiates through a one‑roof model and AI‑driven process optimization.